# Fetal Sex Modulates Hofbauer Cells’ Response to Diabetes in Human Placenta

**Authors:** Zdenek Tauber, Max Mrstik, Adela Burianova, Katerina Koubova, Katerina Cizkova

PMC · DOI: 10.3390/biomedicines13112606 · 2025-10-24

## TL;DR

This study shows that fetal sex influences how Hofbauer cells in the placenta respond to maternal diabetes, with female fetuses showing a more adaptable immune response.

## Contribution

The novel finding is that fetal sex modulates Hofbauer cell response to diabetes, revealing sex-specific immune adaptations in the placenta.

## Key findings

- CD206 intensity in Hofbauer cells is significantly influenced by both maternal diabetes and fetal sex.
- Female fetuses show higher CD206 intensity in controls but a more pronounced reduction under diabetes.
- Apoptotic body accumulation increases with diabetes severity and is higher in male fetuses.

## Abstract

Background: Hofbauer cells (HBCs) are fetal-origin macrophages in the placental villous stroma that contribute to immune tolerance at the feto–maternal interface. They predominantly display an M2 phenotype, characterized by CD206 expression. Methods: Using immunohistochemistry and morphometric analysis, we quantified HBCs, assessed CD206 intensity and morphology, and evaluated apoptotic body accumulation in placental villi. Comparisons were made among pregnancies complicated by type 1 diabetes mellitus (T1DM), gestational diabetes mellitus (GDM), and normoglycemic controls, as well as between male and female fetuses. Results: Significant effects of maternal diabetes and fetal sex on CD206 intensity were observed ([diagnosis: F = 2773.00, p < 0.0001; sex: F = 12.19, p = 0.0005]), with a strong interaction (F = 165.40, p < 0.0001). In controls, CD206 intensity was higher in female than male fetuses (p < 0.0001). Across groups, CD206 intensity decreased progressively from controls to GDM and T1DM, with a more pronounced reduction in females. Reduced CD206 was associated with elongation and irregular HBC morphology and increased IL-1β (r = −0.392, p = 0.003; r = −0.609, p < 0.0001) suggesting less tolerogenic phenotype. For apoptotic bodies, significant main effects of maternal diabetes and fetal sex were detected ([diagnosis: F = 97.16, p < 0.0001; sex: F = 15.88, p = 0.0001]). Accumulation increased progressively from controls to GDM and T1DM, with higher counts in males. Conclusions: Maternal diabetes is associated with reduced CD206 intensity, altered HBC morphology, and accumulation of apoptotic bodies in placental villi. Our results suggest greater HBC plasticity, potentially contributing to a tolerogenic placental environment in females.

## Linked entities

- **Proteins:** MRC1 (mannose receptor C-type 1), IL1B (interleukin 1 beta)
- **Diseases:** type 1 diabetes mellitus (MONDO:0005147), gestational diabetes mellitus (MONDO:0005406)

## Full-text entities

- **Genes:** MRC1 (mannose receptor C-type 1) [NCBI Gene 4360] {aka CD206, CLEC13D, CLEC13DL, MMR, MRC1L1, bA541I19.1}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}
- **Diseases:** T1DM (MESH:D003922), GDM (MESH:D016640), Diabetes (MESH:D003920)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12650028/full.md

---
Source: https://tomesphere.com/paper/PMC12650028